NewsRx

Search our medical news database

Advanced BioPhotonics, Inc.

Imaging company closes on second financing milestone

Published in Medical Device Business Week, February 8th, 2006

Advanced BioPhotonics, Inc., (ABPH) has filed a registration statement on Form SB-2 with the Securities and Exchange Commission completing the second milestone of its previously announced financing.

The company received $1 million in gross proceeds that was payable upon completion of that milestone. An additional $2 million in gross proceeds will be paid at the time the registration statement becomes effective.

"I am glad that ABPH met this milestone in an efficient and timely manner," said Denis O'Connor, CEO of Advanced BioPhotonics. "The proceeds will be used to continue the clinical validation necessary to fuel market adoption and revenue...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Device Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook